Oppenheimer & Co. Inc. Sells 2,337 Shares of Global Medical REIT Inc. (NYSE:GMRE)

Oppenheimer & Co. Inc. lowered its position in shares of Global Medical REIT Inc. (NYSE:GMRE) by 12.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,847 shares of the company’s stock after selling 2,337 shares during the period. Oppenheimer & Co. Inc.’s holdings in Global Medical REIT were worth $130,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Franklin Resources Inc. increased its stake in shares of Global Medical REIT by 228.9% during the third quarter. Franklin Resources Inc. now owns 114,988 shares of the company’s stock worth $1,073,000 after purchasing an additional 80,030 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Global Medical REIT by 158.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company’s stock worth $1,195,000 after buying an additional 73,965 shares in the last quarter. Barclays PLC grew its position in Global Medical REIT by 87.1% during the third quarter. Barclays PLC now owns 154,051 shares of the company’s stock worth $1,527,000 after buying an additional 71,704 shares in the last quarter. State Street Corp grew its position in Global Medical REIT by 1.5% during the third quarter. State Street Corp now owns 1,924,433 shares of the company’s stock worth $19,468,000 after buying an additional 28,444 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in Global Medical REIT by 54.3% during the third quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company’s stock worth $2,298,000 after buying an additional 81,596 shares in the last quarter. Institutional investors own 57.52% of the company’s stock.

Global Medical REIT Trading Up 1.8 %

Shares of NYSE:GMRE opened at $8.96 on Monday. The company has a market capitalization of $598.83 million, a P/E ratio of -447.53, a P/E/G ratio of 1.43 and a beta of 1.26. Global Medical REIT Inc. has a 1 year low of $7.33 and a 1 year high of $10.46. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The business’s 50 day simple moving average is $8.08 and its 200 day simple moving average is $8.73.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.21. The business had revenue of $35.16 million for the quarter, compared to the consensus estimate of $34.87 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. On average, research analysts anticipate that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.

Global Medical REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Friday, March 21st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 9.38%. The ex-dividend date is Friday, March 21st. Global Medical REIT’s dividend payout ratio is currently 8,400.00%.

Global Medical REIT Profile

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.